IQVIA Virtual Trials are bringing studies directly to patients at home. Our virtual trial models offer the flexibility necessary to support sponsors working across therapeutic areas and study types—from complex CNS trials and studies requiring a wide geographic reach to digital therapeutics and long-term follow-up studies. See how combining technology, data science, and clinical expertise speeds recruitment, heightens retention, and improves data quality – all of which helps you accelerate timelines and confidently achieve your study goals.
IQVIA Virtual Trials brings clinical studies directly to patients at home, creating a more human approach to clinical research. By designing trials around patients, participants are surrounded by support, improving recruitment and retention rates, and keeping study plans on track.
At the center of our virtual trials solution is the IQVIA Study Hub™. Built on a highly secure, scalable SaaS platform, Study Hub enables orchestration of all study activities.
From local experts to renowned data scientists, unparalleled data assets to the latest in technology purpose-built for healthcare, the IQVIA CORE integrates everything you need to create a single, seamless virtual trial solution. Customized around your drug, patient population, and development stage, the CORE makes virtual trials a viable solution for you, today.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Decrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.
Access non-identified patient data with IQVIA’s device-agnostic platform that can provide both real-time data and endpoints.
Get in touch today to discover the right solutions for you.
We are pleased to speak with you during our standard business hours.
U.S. Toll-Free only
+1 866 267 4479
For international call please find a number in our toll-free list.